Patricia S Andrews
CIK 1445710 · Chief Commercial Officer · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$62.7K
Companies
4
Total Filings
21
Lifetime Open-Market Net
$112.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ONCY | Director | 78,128 | $0.80 | $62.7K | $30.3K | 2 | 2026-06-03 |
| GERN | Director | — | $1.15 | — | $0 | 1 | 2026-03-26 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | 58,608 | $15.70 | $920.1K | $82.0K | 11 | 2024-05-01 |
| INCY | Chief Commercial Officer | — | $108.53 | — | $0 | 7 | 2012-01-23 |
Recent Filings · Page 2 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-27 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-21 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-21 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-12 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-01-23 | INCY | Grant (A) | — | $0 | EDGAR |
| 2011-01-27 | INCY | Grant (A) | — | $0 | EDGAR |
| 2010-05-25 | INCY | Grant (A) | — | $0 | EDGAR |
| 2010-05-20 | INCY | Grant (A) | — | $0 | EDGAR |
| 2010-01-25 | INCY | Grant (A) | — | $0 | EDGAR |
| 2009-01-29 | INCY | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.